2 completed, 1 not yet recruiting. 1 Not applicable, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Not yet recruiting 1 |
Follow Placebo Dronabinol: new trials by email Literature Review of Placebo Dronabinol trials Research Report on Placebo Dronabinol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dronabinol and Epidiolex to Manage Uncontrolled Residual Symptoms of Buprenorphine Initiation Trial Dronabinol Capsules, Epidiolex 100 mg/mL Oral Solution, Placebo Dronabinol - Opioid Use Disorder | Phase 3 | Not yet recruiting | Montefiore Medical Center | 40 | 2026-10-01 | 2026-06-09 |
| Using Imaging to Assess Effects of THC on Brain Activity Dronabinol, Ethanol, Placebo dronabinol - Intoxication Alcohol, Intoxication THC | Not applicable | Completed | Massachusetts General Hospital | 316 | 2018-11-05 | 2022-07-28 |
| Testing the Interactive Effects of Delta-9-Tetrahydrocannabinol and Pregnenolone: Sub-Study I Active Dronabinol, Active Pregnenolone, Placebo Dronabinol - Healthy | Phase 1 | Completed | Yale University | 13 | 2016-04-07 | 2022-03-02 |
Alcoholic Intoxication (1) · Marijuana Abuse (1) · Opioid-Related Disorders (1) · Psychotic Disorders (1)
Massachusetts General Hospital (1) · Montefiore Medical Center (1) · Yale University (1)
United States (3)
A. Eden Evins, MD, MPH (1) · Deepak Cyril D'Souza, MD (1) · Deepika Slawek, MD, MPH, MS (1) · Jodi M Gilman, PhD (1)
PMID 34999737, PMID 38714786, PMID 41615687
2025 (1), R34DA063987 (1), R42DA043977 (1)